Urogenital Neoplasms: all 135 studies
Page 1 of 2. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate CancerRecruitingNCT07853209Phase 3
- Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition InterventionRecruitingNCT07649681Not applicable
- Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer HospitalNot yet recruitingNCT07606287Not applicable
- Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.RecruitingNCT07572760Not applicable
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 3
- Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)RecruitingNCT07524114
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) StudyNot yet recruitingNCT07389525Early Phase 1
- Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE StudyRecruitingNCT07215624
- A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)RecruitingNCT07103018Phase 1
- High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection MarginsRecruitingNCT06835426Not applicable
- Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical CancerRecruitingNCT06815939Not applicable
- Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerRecruitingNCT06800313Phase 1/2
- Discharge Medication Use Post-Operatively in GU Cancer PatientsRecruitingNCT06795087
- Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06738797
- Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.RecruitingNCT06724159
- Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary CancersRecruitingNCT06717711Phase 3
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate CancerRecruitingNCT06706921Phase 4
- Feasibility Study of CBCT for IGRT in Cancer PatientsRecruitingNCT06681233Not applicable
- CD70-targeted immunoPET Imaging of Kidney CancerRecruitingNCT06680089Phase 2
- Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaRecruitingNCT06676527
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile CancerRecruitingNCT06353906Phase 2
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1
- VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic TherapyRecruitingNCT05920343Phase 2/3
- uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoRecruitingNCT05874921
- Adapting the Tumor Board Model for Mental Illness and CancerRecruitingNCT05837598Not applicable
- Gender Related Coping and Survivorship for Genitourinary CancersRecruitingNCT05649306
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionRecruitingNCT05413850Phase 1/2
- Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy SystemRecruitingNCT05406167
- Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital CancerRecruitingNCT05300308
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital CancerRecruitingNCT05266157Not applicable
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesRecruitingNCT04923178
- Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian CancerRecruitingNCT04519151Phase 2
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
- Personalized Treatment of Urogenital Cancers Depends on the MicrobiomeRecruitingNCT03962920Not applicable
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruitingNCT03866382Phase 2
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
- Genomic Investigation of Unusual RespondersRecruitingNCT03740503
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerRecruitingNCT03412877Phase 2
- Ontario-wide Cancer TArgeted Nucleic Acid EvaluationRecruitingNCT02906943
- Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute ExperienceRecruitingNCT02557230
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerRecruitingNCT01174121Phase 2
- A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Active, not recruitingNCT05288166Phase 3Results posted
- Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer TrialCompletedNCT04679675Not applicableResults posted
- Description of the Population With Genitourinary Tumors and COVID-19CompletedNCT04578132Results posted
- High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical ProstatectomyTerminatedNCT04461509Phase 2Results posted
- Trial of NanoPac Focal Therapy for Prostate CancerTerminatedNCT04221828Phase 2Results posted
- CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder CancerActive, not recruitingNCT03933826Results posted
- Evaluation of NanoDoce® in Participants With Urothelial CarcinomaCompletedNCT03636256Phase 1/2Results posted
- Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerTerminatedNCT03480152Phase 1/2Results posted
- Health Gatherings - For Your Health After CancerCompletedNCT03344757Not applicableResults posted
- Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder CancerCompletedNCT03081858Phase 1/2Results posted
- Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)CompletedNCT02060370Phase 2Results posted
- A Trial for Patients With Advanced/Recurrent Endometrial CancerCompletedNCT00377520Phase 2Results posted
- A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle ContrastTerminatedNCT00147238Not applicableResults posted
- Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical VentilaWithdrawnNCT07111039Not applicable
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsActive, not recruitingNCT07038369Phase 1
- Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor TherapyCompletedNCT06495008
- Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2CompletedNCT06384417Not applicable
- Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic CancerActive, not recruitingNCT06253520Phase 1
- Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabActive, not recruitingNCT06237920Phase 2
- [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT06229366Phase 1
- Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionCompletedNCT06168825
- Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care PlanningCompletedNCT06028152Not applicable
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)TerminatedNCT05935748Phase 2
- Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsActive, not recruitingNCT05902520Phase 1
- Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial NephrectomyActive, not recruitingNCT05887245
- Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor TherapyCompletedNCT05707286
- Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)Active, not recruitingNCT05629065Not applicable
- Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary MalignanciesStatus unknownNCT05597215
- The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support PersonActive, not recruitingNCT05509751Not applicable
- EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCActive, not recruitingNCT05150236Phase 2
- A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerActive, not recruitingNCT05067140Phase 1/2
- Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial CarcinomaStatus unknownNCT05030077Phase 2
- Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/2
- 68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalStatus unknownNCT04831307Not applicable
- Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced DermatitisCompletedNCT04812197Not applicable
- CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and BloodActive, not recruitingNCT04811846Not applicable
- Impact of COVID-19 on GU DiseaseActive, not recruitingNCT04761107
- Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04644432Phase 2
- Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial CancerCompletedNCT04624399Phase 2
- Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
- Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian CancerStatus unknownNCT04566952Phase 2
- Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian CancerStatus unknownNCT04556071Phase 2
- Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesCompletedNCT04501913
- Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedStatus unknownNCT04462926Not applicable
- Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatmentCompletedNCT04435964
- Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or MelanomaActive, not recruitingNCT04407247Phase 1/2
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
- Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary MalignanciesActive, not recruitingNCT04235777Phase 1
- Non-Viral TCR Gene TherapyWithdrawnNCT04102436Phase 2
- Expanded Access to NanoDoceNo longer availableNCT04060628
- Parametric PET of Genitourinary CancerCompletedNCT04020978Not applicable
- A Study of Adaptive Radiation Therapy for Pelvic Genitourinary CancerWithdrawnNCT03909893Not applicable
- Personal Web Page In Clinical Trial Participant EducationCompletedNCT03887091Not applicable